AU2567300A - Inhibition of angiogenesis with epigallocatechin-3-gallate - Google Patents

Inhibition of angiogenesis with epigallocatechin-3-gallate

Info

Publication number
AU2567300A
AU2567300A AU25673/00A AU2567300A AU2567300A AU 2567300 A AU2567300 A AU 2567300A AU 25673/00 A AU25673/00 A AU 25673/00A AU 2567300 A AU2567300 A AU 2567300A AU 2567300 A AU2567300 A AU 2567300A
Authority
AU
Australia
Prior art keywords
epigallocatechin
gallate
angiogenesis
inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25673/00A
Other languages
English (en)
Inventor
Yihai Cao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karolinska Innovations AB
Original Assignee
Karolinska Innovations AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations AB filed Critical Karolinska Innovations AB
Publication of AU2567300A publication Critical patent/AU2567300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU25673/00A 1999-02-12 2000-02-14 Inhibition of angiogenesis with epigallocatechin-3-gallate Abandoned AU2567300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9900473 1999-02-12
SE9900473A SE9900473D0 (sv) 1999-02-12 1999-02-12 Inhibitor of endothelial cell proliferation
PCT/IB2000/000193 WO2000047193A2 (en) 1999-02-12 2000-02-14 Inhibition of angiogenesis with epigallocatechin-3-gallate

Publications (1)

Publication Number Publication Date
AU2567300A true AU2567300A (en) 2000-08-29

Family

ID=20414446

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25673/00A Abandoned AU2567300A (en) 1999-02-12 2000-02-14 Inhibition of angiogenesis with epigallocatechin-3-gallate

Country Status (3)

Country Link
AU (1) AU2567300A (sv)
SE (1) SE9900473D0 (sv)
WO (1) WO2000047193A2 (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781949B2 (en) * 2000-01-14 2005-06-23 Color Access, Inc. Use of epigallocatechin-gallate for inhibiting angiogenesis

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000074662A2 (en) * 1999-06-07 2000-12-14 University Of Sheffield Arthritis treatment
GB0103742D0 (en) * 2001-02-15 2001-04-04 William Ransom & Son Plc Wound healing
WO2002064178A1 (en) * 2001-02-15 2002-08-22 William Ransom & Son Plc Use of green tea extract for wound healing
IL162760A0 (en) 2001-12-28 2005-11-20 Metatasis Res Dev Foundation Polyphenol inhibition of nucleosidediphosphate kinase-b activity and cancer
FR2842102B1 (fr) * 2002-07-10 2005-10-28 Cep Utilisation d'un extrait de the pour controler la liberation d'il8, cytokine pro-inflammatoire et son incorporation dans des preparations cosmetiques et/ou dermatologiques
PT102931B (pt) * 2003-03-28 2005-08-31 Univ Do Porto Utilizacao de bloqueadores da inibicao a longo termo das actividades da atpase na+k+e/ou do trocador na+/h+, na preparacao de um medicamento destinado a terapiaintestinal
CA2527052A1 (en) 2003-05-28 2005-01-06 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Angiogenic agents from plant extracts, gallic acid, and derivatives
KR100601080B1 (ko) 2004-08-26 2006-07-19 가톨릭대학교 산학협력단 (-)-에피갈로카테킨 갈레이트를 유효성분으로 하는류마티스성 관절염 치료제
US20070249545A1 (en) * 2004-08-27 2007-10-25 Rodriguez-Lopez Jose N Dihydrofolate reductase inhibition by epigallocatechin gallate compounds
EP1704862A1 (en) * 2005-03-24 2006-09-27 Rottapharm S.p.A. 2,5-bis(tetrahydroxybutyl)pyrazines for the treatment of osteoarthritis and rheumatoid arthritis
DE102005029845B4 (de) 2005-06-27 2017-03-23 Orgentec Diagnostika Gmbh Verfahren zur Diagnose von rheumatischen Erkrankungen
EP2044951A1 (en) 2007-10-02 2009-04-08 Merz Pharma GmbH & Co. KGaA The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases
US20090226547A1 (en) * 2008-03-05 2009-09-10 Gilbard Jeffrey P Dietary Supplement For Eye Health
TW201412325A (zh) 2012-06-20 2014-04-01 梅茲製藥有限兩合公司 用於治療患有青光眼及其他退化性眼疾之人類視力喪失的間隔醫療
CN108272794A (zh) * 2018-01-17 2018-07-13 苏州大学 表没食子儿茶素没食子酸酯的应用
CN114948935B (zh) * 2022-03-28 2024-05-17 厦门大学 一种没食子酸衍生物纳米药物、制备方法及应用
WO2024170772A1 (en) * 2023-02-17 2024-08-22 Mim Neurosciences Ab Epigallocatechin-3-gallate (egcg) analogs for use in the treatment of diseases in which an increase of nad+ is beneficial such as glaucoma

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61238728A (ja) * 1985-04-16 1986-10-24 Mitsui Norin Kk 茶葉抽出物と活性水酸化アルミニウムとの抗潰瘍性複合体
JP2903318B2 (ja) * 1989-04-04 1999-06-07 日研フード株式会社 抗酸化的ストレス物
JP3002919B2 (ja) * 1991-11-25 2000-01-24 太陽化学株式会社 胃炎，胃または十二指腸潰瘍防止組成物
JPH08217674A (ja) * 1995-02-16 1996-08-27 Noda Sangyo Kagaku Kenkyusho ヒスチジン脱炭酸酵素阻害剤
IT1275905B1 (it) * 1995-03-14 1997-10-24 Indena Spa Frazioni polifenoliche di te', loro uso e formulazioni che le contengono
AU689036B2 (en) * 1995-05-10 1998-03-19 Kureha Chemical Industry Co., Ltd. Pharmaceutical composition containing substance inhibiting HSP47 production
JPH09227374A (ja) * 1996-02-28 1997-09-02 Taiyo Kagaku Co Ltd ストレスタンパク質産生抑制組成物
DE19627344A1 (de) * 1996-07-01 1998-01-08 Vitasyn Gmbh Entwicklung & Ver Therapeutisch wirksame bzw. gesundheitsfördernde Zubereitung aus definierten Polyphenolverbindungen
US5922756A (en) * 1998-02-14 1999-07-13 Chan; Marion Man-Ying Method of inhibiting nitric oxide synthase
JP4507027B2 (ja) * 1998-12-04 2010-07-21 明治乳業株式会社 Ｍｍｐ阻害剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781949B2 (en) * 2000-01-14 2005-06-23 Color Access, Inc. Use of epigallocatechin-gallate for inhibiting angiogenesis

Also Published As

Publication number Publication date
WO2000047193A3 (en) 2001-12-06
WO2000047193A2 (en) 2000-08-17
SE9900473D0 (sv) 1999-02-12

Similar Documents

Publication Publication Date Title
AU6714700A (en) Cyclopropylindole derivatives
AU2600800A (en) Promotion or inhibition of angiogenesis and cardiovascularization
AU2567300A (en) Inhibition of angiogenesis with epigallocatechin-3-gallate
AU4458700A (en) Uses of phenylglycine derivatives
AU3495200A (en) Actuation of downhole devices
AU7947000A (en) Tricyclic fused-imidazole derivatives
AU5429000A (en) Novel bicyclonucleoside derivatives
AU2596700A (en) Promotion or inhibition of angiogenesis and cardiovascularization
AU7319800A (en) 4-oxybenzopyran derivative
AU3670000A (en) Novel thiazolobenzimidazole derivatives
AU7952800A (en) 2-alkoxybenzene derivatives
AU7453900A (en) 4-oxybenzopyran derivative
AU4369000A (en) Inhibition of complement action
AU1082701A (en) Short segments of dap-kinase
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
AU5433699A (en) Spacing of tiles
AU5166700A (en) C-cam as an angiogenesis inhibitor
AU1304801A (en) Tricyclic azaindolizine derivatives having an SPLA2- inhibiting effect
AU5252900A (en) Novel isocoumarin derivatives inhibiting angiogenesis
AU1558300A (en) 1-cycloalkylpyrazoyl-benzoyl derivatives
AU6262300A (en) Indolinylamide derivatives
AU7711800A (en) Novel uses of 2-bromopalmitate
AU2028401A (en) 3-methyl-chromane or thiochromane derivatives
AU5666800A (en) Difuropyrone derivatives
AU1888201A (en) 3-ethyl-, 3-propyl- or 3-butyl-chroman and -thiochroman derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase